COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
002
[키워드] Activation
age
analyses
Analysis
Anti-CD20 antibody
B-cell
biospecimens
CD4
CD8
Cell
cellular and molecular
Chemotherapy
Clinical course
Clinical deterioration
clinically
Cohort
colony stimulating factor
complement
conducted
coronavirus disease
COVID-19
COVID-19 in patient
depleting
functional
Gene expression analysis
granulocyte
had more
Hospitalization
Hospitalized
hyperinflammation
ICU
Immune cell
immune profiling
Immunochemotherapy
immunological
In vitro assay
Inflammatory response
interferon signaling
longitudinal
lymphoma
lymphomas
mechanical ventilation
median
monocytes/macrophages
mononuclear cell
Neutrophils
Patient
patients
performed
Peripheral blood
receiving
required
respiratory specimen
responses
SARS-CoV-2
SARS-CoV-2 antibody response
subsequent
Support
virological study
[DOI] 10.1097/HS9.0000000000000603 PMC 바로가기 [Article Type] 002
[DOI] 10.1097/HS9.0000000000000603 PMC 바로가기 [Article Type] 002